Cognitive Remediation in Early Phase Psychosis
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of the study is to investigate the effect of a 30 hour cognitive remediation program for young patients with early phase schizophrenia spectrum disorders on cognitive, clinical and functional outcome measures. The remediation program is integrated with whatever active rehabilitation the participant is currently attending (school, work, day program etc).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Sep 2009
Typical duration for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 12, 2012
CompletedFirst Posted
Study publicly available on registry
March 7, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedMarch 7, 2012
March 1, 2012
4.3 years
January 12, 2012
March 1, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
MATRICS Consensus Cognitive Battery (MCCB)
Included in the MCCB are measures of the following cognitive domains: Speed of Processing, Attention, Working memory, Verbal learning, Visual Learning, Reasoning and problem solving and Social Cognition. In addition the following tests are included: HVLT-R and BVMT-R delayed recall to measure memory, TMTB (Halstead Reitan) and Color Word Inteference Test (D-KEFS) to measure executive functioning), Digit span (WAIS-III)to measure working memory, Grooved Pegboard (Halstead Reitan) to measure motor function.
Change in MCCB performance from baseline to 4 months and 9 months
UCSD Performance Based Skilled Assessment Brief Version (UPSA-B)
Change in UPSA-B performance from baseline to 4 months and 9 months
Cognitive Assessment Interview (CAI)
Change in CAI scores from baseline to 4 months and 9 months
Social Functioning Scale (SFS)
Change in SFS scores from baseline to 4 months and 9 months
Secondary Outcomes (4)
Calgary Depression Scale
Change in CDS scores from baseline to 4 months and 9 months
Global Assessment of Function (GAF)- split version
Change in GAF scores from baseline to 4 months and 9 months
event related fMRI
Change in BOLD fMRI signal from baseline to 4 months
Rosenberg Self-Esteem Scale (RSES)
Change in RSES scores from baseline to 4 months and 9 months
Study Arms (2)
Cognitive remediation
EXPERIMENTAL30 hour computer based cognitive remediation integrated in participants current rehabilitation program (school, work, day program)
Wait list control group
NO INTERVENTIONParticipant continues in treatment/rehabilitation program as usual until 9 month assessment when participant receives the same cognitive remediation program as the experimental group.
Interventions
Cognitive remediation including feedback from neurocognitive assessment, psychoeducation about cognitive deficits, 30 hours of computer based drill and practise and strategy coaching based cognitive remediation, 1-3 collaborative meetings with cognitive specialist, participant, therapist and teacher, occupational therapist or other therapist (depending on participants rehabilitation situation) to enhance transfer of skills to daily functioning
Eligibility Criteria
You may qualify if:
- Early phase schizophrenia, schizoaffective disorder, psychosis NOS
- Less than 5 years since start of adequate treatment for psychotic disorder
- Age between 18-40
- Norwegian speaking (sufficiently to understand and complete assessments)
You may not qualify if:
- Traumatic brain injury
- Neurological disorder as determined by medical history
- IQ below 70
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- Stiftelsen Helse og Rehabiliteringcollaborator
- South-Eastern Norway Regional Health Authoritycollaborator
Study Sites (1)
Psychosis Research Unit, Division of Mental Health and Addiction, Oslo University Hospital.
Oslo, 0407, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Torill Ueland, PhD
Psychosis Research Unit, Division of Mental Health and Addiction, Oslo University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2012
First Posted
March 7, 2012
Study Start
September 1, 2009
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
March 7, 2012
Record last verified: 2012-03